Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohammed Amine BEKADJA"'
Autor:
Mohammed Amine Bekadja
Publikováno v:
Journal de la Faculté de Médecine d'Oran, Vol 7, Iss 1 (2023)
Les infections bactériennes, fongiques ou virales sont des complications fréquentes au cours des procédures de greffes de cellules souches hématopoïétiques, aussi bien au cours des autogreffes qu’au cours des allogreffes en hématologie. Ces
Externí odkaz:
https://doaj.org/article/e605780b245146e0b7932829095cf915
Autor:
Mohammed Amine BEKADJA, Brahim BENZINEB, Mansour BELKACEM, Hafida OUDJERIOUAT, Badra ENTASOLTAN, Soufi OSMANI, Kamila AMANI, Samira BOUCHAMA, Leila CHAREF, Mohamed BRAHIMI, Abdessamad ARABI, Rachir Amar BOUHASS, Nabil YAFOUR
Publikováno v:
Journal de la Faculté de Médecine d'Oran, Vol 6, Iss 1 (2022)
Introduction-The objectives of our work are to measure the incidence of thrombosis and identify predictive factors during the procedure of autologous hematopoietic stem cells, during real life, in the University Hospital of Oran (Algeria). Methods-Th
Externí odkaz:
https://doaj.org/article/897100b6246e48f78c8d74db1c6eef1b
Autor:
Benkhira Nadjia, Zouaoui Zahia, Chekkaf Ismahane, Brahim Benzineb, Hadj Touhami, Othman Ibraheem, A Bachiri, Djamel Saidi, Asma Hadjeb, Mohamed Aberkane, Mohammed Amine Bekadja, Bendahmane Ahmed Fouad, Amina Krim, Mesli Naima, Samira Zouani, N Mehalhal, Faiza Bensmail
Publikováno v:
Blood. 132:5189-5189
Introduction: Death during induction therapy remains a problem in the management of acute myeloid leukemia (AML). An estimated 6.1% in adult patients and between 19.3% and 27% in subjects of all ages have died of AML during induction therapy. The pur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9636317e098e1cae5e33f3674771bc4a
https://doi.org/10.1182/blood-2018-99-112430
https://doi.org/10.1182/blood-2018-99-112430
Autor:
Mohammed Amine Bekadja
Publikováno v:
Journal of Blood & Lymph.
In lymphoma, the protocols used were of more different type: CBV, BEAM [3], BEAC [4] CEAM [5], FEAM [6] or LACE [7]. CBV and BEAM are the two most frequently used regimens for patients with lymphoma undergoing autologous progenitor cells transplantat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c67a28f0eee41e34c0e36db357a698e
https://doi.org/10.4172/2165-7831.1000e115
https://doi.org/10.4172/2165-7831.1000e115
Autor:
Claire Lacan, Jérôme Lambert, Edouard Forcade, Marie Robin, Patrice Chevallier, Sandrine Loron, Claude-Éric Bulabois, Corentin Orvain, Patrice Ceballos, Etienne Daguindau, Amandine Charbonnier, Yves Chalandon, Marc Bernard, Célestine Simand, Marie-Thérèse Rubio, Pascal Turlure, Johan Maertens, Anne Huynh, Michael Loschi, Jacques-Olivier Bay, Gaëlle Guillerm, Mustafa Alani, Cristina Castilla-Llorente, Xavier Poiré, Sylvain Chantepie, Natacha Maillard, Yves Beguin, Ambroise Marçais, Jérôme Cornillon, Jean-Valère Malfuson, Sébastien Maury, Nathalie Meuleman, Alban Villate, Mohammed-Amine Bekadja, Anouk Walter-Petrich, Nathalie Jacque, Micha Srour, Raynier Devillier, Stéphanie Nguyen
Publikováno v:
Journal of Hematology & Oncology, Vol 17, Iss 1, Pp 1-5 (2024)
Abstract The use of peripheral blood (PB) or bone marrow (BM) stem cells graft in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide (PTCy) for graft-versus-host disease (GVHD) prophylaxis remains controversi
Externí odkaz:
https://doaj.org/article/06528184135d4dc9a33935cb6d4ee598